• News

PCSK9 Inhibitors for Severe COVID? Pilot Trial Signals of Benefit

  • Medscape
  • New York, NY
  • (January 20, 2023)

Robert Rosenson, MD, discusses a study suggesting that PCSK9 inhibitors, a cholesterol-lowering medication, can directly modulate inflammation in COVID-19.

Read more